Biotin

Biotin

SCHEMBL5960334

NCCO.O=C(O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MPL

The experimentally established mechanism targets of Biotin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 6/20 0.85
MEN1 O00255 1/20 0.85
ABL1 P00519 1/20 0.85
LMNA P02545 1/20 0.85
PKM P14618 1/20 0.85
IDE P14735 1/20 0.85
MAPK1 P28482 1/20 0.85
KMT2A Q03164 1/20 0.85
RIN1 Q13671 1/20 0.85
L3MBTL1 Q9Y468 1/20 0.85
HLCS P50747 6/20 0.67
CA12 O43570 7/20 0.53
CA1 P00915 7/20 0.53
CA2 P00918 7/20 0.53
CA9 Q16790 7/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biotin SCHEMBL453833 0.95 TDP1 (0.90) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL2057282 0.94 TDP1 (0.87) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL6865574 0.94 TDP1 (0.87) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL3425472 0.93 TDP1 (0.85) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL770770 0.93 TDP1 (0.85) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL739967 0.93 TDP1 (0.85) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL20473405 0.92 TDP1 (0.90) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL636444 0.92 TDP1 (0.94) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL1199492 0.92 TDP1 (0.94) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL23055065 0.92 TDP1 (1.00) TDP1MEN1ABL1LMNAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3027166-A2 FORMULATIONS CONTAINING SPHINGANINE Evonik Degussa GmbH (DE) 2016-06-08 EP claimed
WO-2015014558-A2 FORMULATIONS CONTAINING SPHINGANINE EVONIK INDUSTRIES AG (DE) 2015-02-05 WO claimed
WO-2025119790-A1 COMPOSITION COMPRISING CERAMIDE AND TRIGLYCERIDE EVONIK OPERATIONS GMBH (DE) 2025-06-12 WO disclosed
EP-3027166-A2 FORMULATIONS CONTAINING SPHINGANINE Evonik Degussa GmbH (DE) 2016-06-08 EP disclosed
WO-2015014558-A2 FORMULATIONS CONTAINING SPHINGANINE EVONIK INDUSTRIES AG (DE) 2015-02-05 WO disclosed
EP-1507849-A4 METHODS AND COMPOSITIONS FOR EXPANDING AND DIFFERENTIATING INSULIN-PRODUCING CELLS NOVOCELL INC (US) 2006-05-03 EP disclosed
EP-1507849-A1 METHODS AND COMPOSITIONS FOR EXPANDING AND DIFFERENTIATING INSULIN-PRODUCING CELLS NOVOCELL, INC. (US) 2005-02-23 EP disclosed
WO-2003100038-A1 METHODS AND COMPOSITIONS FOR EXPANDING AND DIFFERENTIATING INSULIN-PRODUCING CELLS NOVOCELL, INC. (US) 2003-12-04 WO disclosed